NCT02910102View on ClinicalTrials.gov

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Alzheimer's DiseaseDementia With Lewy BodiesParkinson's Disease Dementia
Interventions
DRUG

RVT-101 35 mg

RVT-101 once daily, oral, 35-mg tablets

DRUG

Placebo

Placebo once daily, oral

Trial Locations (11)

31909

US106, Columbus

32502

US108, Pensacola

33009

US109, Hallandale

33137

US116, Miami

33431

US115, Boca Raton

43210

US111, Columbus

46202

US107, Indianapolis

48106

US102, Ann Arbor

85013

US101, Phoenix

92591

US117, Temecula

93065

US118, Simi Valley

Sponsors
All Listed Sponsors
lead

Axovant Sciences Ltd.

INDUSTRY